Use of Co-Amoxiclav temporarily suspended amidst reports on fatalities

Date:

Colombo (LNW): The use of Co-Amoxiclav, a class of antibiotics, has been temporarily suspended amidst reports on the death of a patient at the Colombo National Hospital, who was treated with the said antibiotic, announced Health Minister Keheliya Rambukwella.

Early reports claimed that a 50-year old person who had arrived from Warakapola to receive treatment at the Colombo National Hospital for a cut wound died upon being administered the antibiotic.

There were 21,000 vaccines in the relevant drug category, and 18,000 of them have been used so far, but the situation is reported only in relation to one vaccine amongst them, the Minister said.

An investigation is also underway through the expert committee appointed to probe into issues related to medicines, he added.

Share post:

spot_imgspot_img

Popular

More like this
Related

Eminent business leaders bestowed with Lifetime Achievement Awards by SLID-ACCA

Mahendra Amarasuriya Ken Balendra (award accepted by Krishan Balendra) Sohli Captain Rohini...

Waste Crisis Meets Opportunity: Can Korean Aid Shift Sri Lanka?

Sri Lanka’s municipal waste management crisis has quietly grown...

Local Investors Power Equity Growth amid Foreign Capital Absence

Sri Lanka’s equity market is entering 2026 on an...

Cyclone Impact “Moderate”? Data Reveals Deeper Economic Fault Lines

Sri Lanka’s corporate leadership has sought to reassure investors...